Group 1 - The core viewpoint of the article indicates that Fudan Zhangjiang (01349) is experiencing a significant decline in stock price, with a drop of 4% during trading and a current price of HKD 3.13, alongside a trading volume of HKD 3.7159 million [1] - The company expects to report an unaudited net loss attributable to shareholders of approximately RMB 120 million to RMB 180 million for the fiscal year ending December 31, 2025, compared to a net profit of RMB 39.73 million in the same period of 2024 [1] - The expected net loss, excluding non-recurring items, is projected to be between RMB 140 million and RMB 200 million, while the net profit for 2024, excluding non-recurring items, was RMB 5.1452 million [1] Group 2 - The company attributes the losses to the advancement of research and development projects, with R&D expenditures rising as a percentage of operating income, amounting to approximately RMB 350 million during the period [1] - Additionally, the retail price of the product "Libao Duo" was reduced starting May 1 of the previous year, leading to a decrease in profit margins, with the product's contribution to the company's profits declining by approximately RMB 100 million year-on-year [1]

Core Viewpoint - The company, DiAo Micro (688381.SH), anticipates a revenue increase for 2025, but expects significant net losses compared to the previous year [1] Financial Performance - The company expects to achieve an annual revenue of approximately 562 million yuan in 2025, representing an increase of 35.75 million yuan, or 6.79%, compared to the previous year [1] - The projected net loss attributable to the parent company for 2025 is estimated to be between 55 million yuan and 82 million yuan, a decrease of 7.93 million to 34.93 million yuan, reflecting a year-on-year decline of 16.85% to 74.22% [1] - The expected net loss excluding non-recurring gains and losses is projected to be between 112 million yuan and 139 million yuan, which is a reduction of 18.32 million to 45.32 million yuan, indicating an increase in losses of 19.56% to 48.38% year-on-year [1] R&D and Market Strategy - The company has been increasing its R&D investment to enhance its product matrix and improve product performance and quality [1] - Despite a competitive market environment, the company's product gross margin remains around 43% [1] - The company has intensified its promotion of new products and expanded downstream sales channels to increase its share among major clients, leading to a combined increase of approximately 13.5% in R&D and sales expenses compared to the previous year, which has contributed to the decline in profits [1]